1.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: DBCG07MRBRCA, NCT00413491
|
|
2.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 5 to 71
Sponsor: Other
Protocol IDs: CSET2011/1748, NCT01464086
|
|
3.
|
Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: FMSU2011-003A, NCT01542814
|
|
4.
|
Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT3.6k-2006, NCT00419679
|
|
5.
|
Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FER2k, NCT00419900
|
|
6.
|
Phase: Phase II
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 35 to 64
Sponsor: NCI
Protocol IDs: TATA-1900215717A1, 1900215717A1, NCT00632047
|
|
7.
|
Phase: Phase II
Type: Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: TOMOSEIN-1104, NCT01612650
|
|
8.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 25 to 80
Sponsor: Other
Protocol IDs: P50CA83636-01, 6973, NCT01121640
|
|
9.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 18 to 64
Sponsor: Other
Protocol IDs: RMNHS-2278, EU-20352, NCT00081003
|
|
10.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: DAMD17-03-1-0447, NCT00117663
|
|
11.
|
Phase: No phase specified
Type: Screening
Status: Approved-not yet active
Age: 20 to 90
Sponsor: Other
Protocol IDs: 9461700528, NCT00173303
|
|
12.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CASE1105, P30CA043703, NCT00445445
|
|
13.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: UHNREB#07-0689-CE, HC#124313, NCT00500383
|
|
14.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: OOTR-SBR001, NCT00509509
|
|
15.
|
Phase: No phase specified
Type: Health services research, Screening
Status: Active
Age: 35 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: SC0001, NCT00649337
|
|
16.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 21 to 50
Sponsor: Other
Protocol IDs: BCA-003, CA126441, CA083597, NCT00671385
|
|
17.
|
Phase: No phase specified
Type: Health services research, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 00-60, NYU H#9541, NCT00849199
|
|
18.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCIRB# 13073B, NCT00989638
|
|
19.
|
Phase: No phase specified
Type: Diagnostic, Screening
Status: Approved-not yet active
Age: 30 to 64
Sponsor: Other
Protocol IDs: WCF-2011-BRA-IND-CAM, NCT01178736
|
|
20.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PROPER/IPC 2010-001, NCT01188915
|
|
21.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 50 to 69
Sponsor: Other
Protocol IDs: 2010/144 (REK), NCT01248546
|
|
22.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: IR 4707, CRC 08108, NCT01292733
|
|
23.
|
Phase: No phase specified
Type: Screening, Supportive care
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: UPCC 12110, NCT01292772
|
|
24.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Screening, Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 354344, NCT01322750
|
|
25.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MTI-2008, 514, NCT01486745
|
Mobile | Español
